$0.9380
0.055.39%
At close: -
$0.9620
0.022.56%
After Hours: Dec 20, 9:13 AM EDT
Indaptus Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Indaptus Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-12 | $-0.32 | $-0.42 | 23.8 % |
Jun 2024 | 2024-08-12 | $-0.47 | $-0.54 | 13.0 % |
Mar 2024 | 2024-05-08 | $-0.45 | $-0.44 | -2.27 % |
Dec 2023 | 2024-03-13 | $-0.46 | $-0.54 | 14.8 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Indaptus Therapeutics (INDP) is scheduled to report earnings on March 12, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
The Actual EPS was $-0.32, which beat the estimate of $-0.42.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.